Paresthesia-Free Fast-Acting Subperception (FAST) Study
← catalyst calendarSponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
177actual
Sites
13
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-02-10 | actual | When the study began enrolling |
| Primary completion | 2022-12-14 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Mar 2029 | estimated | The whole study's end, after follow-up |
| First posted | 2020-11-06 | actual | When this record first appeared on the registry |
| Results posted | 2023-12-29 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-08-12 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Chronic Pain
Intervention
- Device: Boston Scientific WaveWriter SCS System
Primary outcome
what the primary-completion date above is the date OFTargeted Pain Responder Rate
measured 3 months post-activation
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2023-07-12 · 27.0 MB · Prot_SAP_000.pdf
Publications
- PMID 41803572 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed